Skip to main content

GOLDMAN SACHS GROUP INC

Position in CORT — Corcept Therapeutics Inc

CIK 886982 NEW YORK, NY

Position in CORT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$49,432,726
+$20,174,842 QoQ
Shares Held
568,519
-21.7% QoQ
Ownership
0.526%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 423 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in CORT Over Time

Shares Held

Position Value (USD)

Derivatives in CORT

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$869,500
PutShares
10,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. CORT ranks #65 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CORT

Export CSV
32 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $49,432,726 568,519
2026-06-30 $869,500 10,000
2026-03-31 $29,257,884 725,822
2025-12-31 $14,997,964 430,976
2025-09-30 $32,336,936 389,086
2025-06-30 $41,153,104 560,669
2025-03-31 $57,720,733 505,347
2024-12-31 $31,556,535 626,246
2024-09-30 $21,891,411 473,021
2024-06-30 $15,548,868 478,574
2024-06-30 $974,700 30,000
2024-03-31 $10,950,646 434,722
2023-12-31 $17,304,044 532,760
2023-09-30 $11,133,668 408,575
2023-06-30 $8,082,690 363,267
2023-03-31 $8,738,313 403,431
2022-12-31 $9,631,021 474,201
2022-09-30 $10,819,900 421,993
2022-06-30 $7,339,458 308,640
2022-03-31 $7,850,156 348,586
2021-12-31 $6,956,650 351,346
2021-12-31 $330,660 16,700
2021-09-30 $11,000,785 558,983
2021-09-30 $328,656 16,700
2021-06-30 $8,651,170 393,235
2021-06-30 $367,400 16,700
2021-03-31 $11,514,740 484,016
2020-12-31 $3,149,664 120,400
2020-12-31 $13,929,492 532,473
2020-09-30 $8,299,589 476,714
2020-06-30 $16,159,159 960,711
2020-03-31 $10,250,724 862,130